Discounted Cash Flow
Alvotech Foreign
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
| Dividends | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2020 | $66.6m | $-154.2m | $-74.3m | -231.5% | $-1.82 |
| 2021 | $0 (-100.0%) | $86.3m (155.9%) | $-228.2m (-207.1%) | — | $-0.92 (49.5%) |
| 2022 | $24.8m | $-205.2m (-337.9%) | $-361.4m (-58.4%) | -826.2% | $-2.60 (-182.6%) |
| 2023 | $48.7m (96.1%) | $-296.2m (-44.3%) | $-358.7m (0.8%) | -608.2% (26.4%) | $-2.43 (6.5%) |
| 2024 | $273.5m (461.6%) | $-287.2m (3.0%) | $-293.8m (18.1%) | -105.0% (82.7%) | $-0.87 (64.2%) |
| 2025 | $276.3m (1.0%) | $58.1m (120.2%) | $-146.3m (50.2%) | 21.0% (120.0%) | $0.10 (111.5%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.